首页 | 本学科首页   官方微博 | 高级检索  
     

马波沙星在罗非鱼体内的药物代谢动力学研究
引用本文:单奇,白野,范晶晶,刘书贵,尹伊,李丽春,郑光明. 马波沙星在罗非鱼体内的药物代谢动力学研究[J]. 华南农业大学学报, 2017, 38(1): 5-8. DOI: 10.7671/j.issn.1001-411X.2017.01.002
作者姓名:单奇  白野  范晶晶  刘书贵  尹伊  李丽春  郑光明
作者单位:中国水产科学研究院 珠江水产研究所/农业部热带亚热带水产资源利用与养殖重点实验室/农业部水产品质量安全风险评估实验室,广东 广州,510380
基金项目:国家自然科学基金(31502125);广东省自然科学基金-博士启动基金(2015A030310086);农业部水产品质量安全风险评估项目(GJFP201501001)
摘    要:【目的】研究马波沙星在罗非鱼Oreochromis niloticus体内的药物代谢动力学(简称药动学)特征,为临床合理用药提供参考。【方法】将罗非鱼随机分成2组,水温维持在30℃,以10 mg·kg-1分别单剂量肌内注射和口服给药,高效液相色谱(HPLC)-荧光检测法测定血浆中马波沙星的质量浓度,用Win Nonlin 6.1药动学软件的"非房室模型"分析药动学参数。【结果】肌内注射马波沙星后,药物吸收和消除均较口服快,体内分布广泛。达峰时间(tmax)为0.25 h,峰质量浓度(ρmax)为4.31μg·mL~(-1),消除半衰期(t1/2λz)为19.21 h,表观分布容积为3.94L·kg-1,药-时曲线下面积(AUC)为70.36μg·mL~(-1)·h-1。口服马波沙星后,药物吸收和消除均较慢,体内分布广泛。tmax为4.00 h,ρmax为2.45μg·mL~(-1),t1/2λz为22.67 h,表观分布容积为4.27 L·kg-1,AUC为76.66μg·mL~(-1)·h-1。【结论】10 mg·kg-1马波沙星能够有效治疗大多数敏感菌引起的罗非鱼感染。

关 键 词:马波沙星  罗非鱼  药物代谢动力学  高效液相色谱
收稿时间:2016-04-01

Pharmacokinetics of marbofloxacin in tilapia (Oreochromis niloticus)
SHAN Qi,BAI Ye,FAN Jingjing,LIU Shugui,YIN Yi,LI Lichun and ZHENG Guangming. Pharmacokinetics of marbofloxacin in tilapia (Oreochromis niloticus)[J]. JOURNAL OF SOUTH CHINA AGRICULTURAL UNIVERSITY, 2017, 38(1): 5-8. DOI: 10.7671/j.issn.1001-411X.2017.01.002
Authors:SHAN Qi  BAI Ye  FAN Jingjing  LIU Shugui  YIN Yi  LI Lichun  ZHENG Guangming
Affiliation:Pearl River Fisheries Research Institute, Chinese Academic of Fishery Science/Key Laboratory of Tropical and Subtropical Fishery Resource Application and Cultivation of Ministry of Agriculture/Ministry of Agriculture Laboratory of Quality & Safety Risky Assessment for Aquatic Product,,Pearl River Fisheries Research Institute, Chinese Academic of Fishery Science/Key Laboratory of Tropical and Subtropical Fishery Resource Application and Cultivation of Ministry of Agriculture/Ministry of Agriculture Laboratory of Quality & Safety Risky Assessment for Aquatic Product,,Pearl River Fisheries Research Institute, Chinese Academic of Fishery Science/Key Laboratory of Tropical and Subtropical Fishery Resource Application and Cultivation of Ministry of Agriculture/Ministry of Agriculture Laboratory of Quality & Safety Risky Assessment for Aquatic Product,,Pearl River Fisheries Research Institute, Chinese Academic of Fishery Science/Key Laboratory of Tropical and Subtropical Fishery Resource Application and Cultivation of Ministry of Agriculture/Ministry of Agriculture Laboratory of Quality & Safety Risky Assessment for Aquatic Product,,Pearl River Fisheries Research Institute, Chinese Academic of Fishery Science/Key Laboratory of Tropical and Subtropical Fishery Resource Application and Cultivation of Ministry of Agriculture/Ministry of Agriculture Laboratory of Quality & Safety Risky Assessment for Aquatic Product,,Pearl River Fisheries Research Institute, Chinese Academic of Fishery Science/Key Laboratory of Tropical and Subtropical Fishery Resource Application and Cultivation of Ministry of Agriculture/Ministry of Agriculture Laboratory of Quality & Safety Risky Assessment for Aquatic Product, and Pearl River Fisheries Research Institute, Chinese Academic of Fishery Science/Key Laboratory of Tropical and Subtropical Fishery Resource Application and Cultivation of Ministry of Agriculture/Ministry of Agriculture Laboratory of Quality & Safety Risky Assessment for Aquatic Product,
Abstract:Objective] To study the pharmacokinetics characteristics of marbofloxacin in tilapia ( Oreo-chromis niloticus) , and provide references for rational clinical drug usage.[Method]The tilapia were di-vided into two groups for intramuscular ( i. m. ) and oral administrations, and each fish received marbo-floxacin at a dosage of 10 mg·kg-1 body mass. Water temperature was maintained at 30 ℃. The con-centration of marbofloxacin in plasma was measured using high performance liquid chromatography ( HPLC) combined with fluorescence detection. The plasma drug concentration-time data were analyzed by the non-compartment model of WinNonlin 6. 1 software.[Result]After i. m. administration, marbo-floxacin absorption and elimination were relatively faster, and it was widely distributed throughout the body. Peak time of plasma concentration ( tmax ) was 0. 25 h, the maximum plasma concentration (ρmax ) was 4. 31 μg·mL-1 , the elimination half-life ( t1/2λz ) was 19. 21 h, the volume of distribution was 3. 94 L·kg-1 and the area under the plasma concentration-time curve ( AUC) was 70. 36 μg·mL-1·h-1 . Fol-lowing oral administration, marbofloxacin absorption and elimination were relatively slower, and it was widely distributed throughout the body. tmax was 4. 00 h, ρmax was 2. 45 μg·mL-1 , t1/2λz was 22. 67 h, the volume of distribution was 4. 27 L·kg-1 and AUC was 76. 66 μg·mL-1 ·h-1 .[Conclusion]Using 10 mg·kg-1 marbofloxacin could effectively control susceptible micro-organisms involved in most com-mon infections in tilapia.
Keywords:marbofloxacin   Oreochromis niloticus   pharmacokinetics   HPLC
本文献已被 CNKI 万方数据 等数据库收录!
点击此处可从《华南农业大学学报》浏览原始摘要信息
点击此处可从《华南农业大学学报》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号